We have so far defined two HLA-A sub-alleles, namely HLA-A*02:01 and HLA-A*24:02, with clearly opposite, direct, or indirect, effects on the clinical progression of PCa from diagnosis to early BCR (for LPCa patients treated with localized therapy), CR and, more importantly to death (OS). This evidence concerns the gene BCR and posterior cortical atrophy.